Stereotactic body radiotherapy for central lung tumors, yes we can!

BACKGROUND: SBRT is standard therapy for early stage lung cancer. Toxicity in central tumors has been a concern. RTOG 0813 showed that central SBRT is safe and effective. We report our experience with central SBRT. METHODS: We reviewed the records of patients treated with SBRT for central lung tumor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol
Hlavní autoři: Korzets ceder, Yasmin, Fenig, Eyal, Popvtzer, Aron, Peled, Nir, Kramer, Mordechai R., Saute, Milton, Bragilovsky, Dima, Schochat, Tzippy, Allen, Aaron M.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918762/
https://ncbi.nlm.nih.gov/pubmed/29695273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1017-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky